Total Payments
$4,621
2024 Payments
$586.25
Companies
21
Transactions
122
Medicare Patients
6,881
Medicare Billing
$3.1M
Payment Breakdown by Category
Food & Beverage$3,353 (72.6%)
Other$1,250 (27.1%)
Education$17.84 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,353 | 120 | 72.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,250 | 1 | 27.1% |
| Education | $17.84 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,284 | 3 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $622.61 | 16 | $0 (2024) |
| Genentech USA, Inc. | $528.36 | 16 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $488.09 | 20 | $0 (2024) |
| ABBVIE INC. | $395.12 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $279.71 | 6 | $0 (2021) |
| Horizon Therapeutics plc | $238.68 | 11 | $0 (2023) |
| Allergan, Inc. | $127.62 | 8 | $0 (2022) |
| Apellis Pharmaceuticals, Inc. | $121.85 | 1 | $0 (2022) |
| Amgen Inc. | $112.00 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $586.25 | 24 | Alexion Pharmaceuticals, Inc. ($151.90) |
| 2023 | $631.27 | 24 | Genentech USA, Inc. ($212.26) |
| 2022 | $761.29 | 22 | Regeneron Healthcare Solutions, Inc. ($155.54) |
| 2021 | $247.24 | 13 | Horizon Therapeutics plc ($66.12) |
| 2020 | $133.63 | 7 | Horizon Therapeutics plc ($40.59) |
| 2019 | $1,862 | 13 | Bausch & Lomb, a division of Bausch Health US, LLC ($1,267) |
| 2018 | $140.24 | 8 | Allergan Inc. ($56.28) |
| 2017 | $258.65 | 11 | Regeneron Healthcare Solutions, Inc. ($136.84) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: Rare Disease | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/05/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: Rare Disease | ||||||
| 05/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/24/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Rare Disease | ||||||
| 03/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: OPTOMETRY | ||||||
| 01/24/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Rare Disease | ||||||
| 01/16/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Rare Disease | ||||||
| 01/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,100 | 5,687 | $683,536 | $416,861 |
| 2022 | 12 | 1,441 | 3,610 | $973,744 | $590,601 |
| 2021 | 16 | 2,031 | 5,405 | $1.4M | $904,345 |
| 2020 | 15 | 2,309 | 6,536 | $1.8M | $1.2M |
Total Patients
6,881
Total Services
21,238
Medicare Billing
$3.1M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 31 | 144 | $144,000 | $100,062 | 69.5% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2023 | 17 | 384 | $129,600 | $95,286 | 73.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 15 | 3,060 | $128,520 | $89,493 | 69.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 417 | 612 | $94,860 | $53,022 | 55.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 135 | 396 | $71,280 | $33,967 | 47.7% |
| 92134 | Imaging of retina | Office | 2023 | 366 | 838 | $58,660 | $23,683 | 40.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 67 | 194 | $48,500 | $17,724 | 36.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 21 | 27 | $3,240 | $1,828 | 56.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,220 | $1,337 | 41.5% |
| 92250 | Photography of the retina | Office | 2023 | 17 | 18 | $1,656 | $458.68 | 27.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 65 | 346 | $346,000 | $247,931 | 71.7% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2022 | 25 | 438 | $147,825 | $108,248 | 73.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 495 | 717 | $111,110 | $60,511 | 54.5% |
| J3490 | Unclassified drugs | Office | 2022 | 13 | 33 | $99,000 | $58,738 | 59.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 174 | 571 | $102,530 | $49,978 | 48.7% |
| 92134 | Imaging of retina | Office | 2022 | 462 | 1,078 | $75,220 | $30,665 | 40.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 101 | 303 | $75,620 | $26,989 | 35.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 26 | 42 | $5,015 | $2,637 | 52.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 19 | 19 | $3,420 | $1,862 | 54.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,160 | $1,452 | 45.9% |
| 92250 | Photography of the retina | Office | 2022 | 35 | 35 | $3,220 | $960.07 | 29.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 12 | 14 | $1,624 | $629.65 | 38.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 87 | 616 | $616,000 | $451,829 | 73.3% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2021 | 40 | 738 | $249,075 | $184,857 | 74.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 325 | 966 | $171,902 | $85,107 | 49.5% |
About Dr. Melvin Chen, MD
Dr. Melvin Chen, MD is a Ophthalmology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194772574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melvin Chen, MD has received a total of $4,621 in payments from pharmaceutical and medical device companies, with $586.25 received in 2024. These payments were reported across 122 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,353).
As a Medicare-enrolled provider, Chen has provided services to 6,881 Medicare beneficiaries, totaling 21,238 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Sarasota, FL
- Active Since 05/30/2006
- Last Updated 11/06/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1194772574
Products in Payments
- ENVISTA (Device) $1,250
- EYLEA (Biological) $365.44
- ULTOMIRIS (Biological) $315.85
- Lucentis (Biological) $269.07
- TEPEZZA (Drug) $215.54
- Vabysmo (Drug) $214.67
- BOTOX (Biological) $209.54
- OZURDEX (Drug) $160.37
- EYLEA AFLIBERCEPT INJECTION (Biological) $156.18
- SOLIRIS (Biological) $128.15
- Empaveli (Drug) $121.85
- BUPARLISIB (Drug) $121.75
- EYLEA HD (Biological) $100.99
- PURIFIED CORTROPHIN GEL (Drug) $86.66
- Cequa (Drug) $77.09
- UBRELVY (Drug) $73.19
- TEPEZZA (Biological) $65.88
- BEOVU (Drug) $54.04
- XIIDRA (Drug) $52.74
- XEOMIN (Biological) $49.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Sarasota
Dr. Daniel Kiernan, Md, MD
Ophthalmology — Payments: $1.9M
Ophthalmology $1.9M
Dr. Jody Abrams, M.d, M.D
Ophthalmology — Payments: $364,132
Ophthalmology $364,132
Keye Wong, M.d, M.D
Ophthalmology — Payments: $29,735
Ophthalmology $29,735
Dr. Marc Levy, Md, MD
Ophthalmology — Payments: $18,348
Ophthalmology $18,348
Tanuj Banker, M.d, M.D
Ophthalmology — Payments: $16,580
Ophthalmology $16,580
John Niffenegger, Md, MD
Ophthalmology — Payments: $15,775
Ophthalmology $15,775